Closure of Sde Avraham farm in Israel optimizes Company’s organizational structure by fully leveraging global import-export supply chain Increase in Revolving Credit Facility availability to $15 million supports increased...
IM Cannabis Reports Record Fourth Quarter and Fiscal Year 2021 Financial Results and Provides First Quarter 2022 Outlook Fiscal Year 2021 revenues increased 242% year-over-year to a record of...
Transaction expands IMC’s footprint into Israel’s largest city while positioning the Company as one of the largest retailers of medical cannabis in the country TORONTO, and GLIL YAM, Israel,...
IM Cannabis Closes Three Previously Announced Strategic Acquisitions in Israel All Requisite Approvals Received by Company to Complete Vironna, Pharm Yarok, and Panaxia Transactions TORONTO and GLIL YAM, Israel,...
IM Cannabis Reports Record Preliminary Fourth Quarter and Full Year 2021 Financial Results Q4 2021 revenues expected to be at least $20 million, an increase of at least 308%...
IM Cannabis announces Focus Medical’s Import of 400 Kilograms of Premium-Indoor-Grown Dried Cannabis from Canada to Israel The successful import demonstrates the strength of the IM Cannabis global supply...
IM Cannabis Corp. Appoints Rinat Efrima as New Chief Executive Officer of IMC Holdings, the Company’s Israeli Subsidiary Oren Shuster remains Chief Executive Officer and Director of IM Cannabis...
IM Cannabis to Acquire Oranim, Jerusalem’s Leading Medical Cannabis Pharmacy Transaction positions IM Cannabis as one of the largest retailers of medical cannabis in Israel; Retail segment combined annualized...
IM Cannabis Announces Focus Medical’s Receipt of Israeli Ministry of Health Import Permit; Plans to Launch WAGNERS Brand in Israel IM Cannabis’ popular recreational cannabis brand WAGNERS will be...
TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / September 8, 2021 / IM Cannabis Corp. (“IMC” or the “Company”) (CSE:IMCC) (NASDAQ:IMCC), a multi-country operator (“MCO”) in the medical and...
Exclusive Interview with IM Cannabis Co-Founder and CEO Oren Shuster IM Cannabis (CSE: IMCC) (NASDAQ: IMCC) has become an international player in the cannabis industry. The company started in...
IM Cannabis Announces Q2 2021 Financial Results and Signing of Definitive Agreement to Acquire Vironna Pharm, Accelerating its Vertical Integration Strategy in Israel Q2 2021 revenues of $11.1 million,...
IMC Partners with Leading US Brand to Launch cbdMD Products in Israel and Provides Further Details on Panaxia Transaction TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / August...
IMC Accelerates its Israeli Retail Position through Acquisition of Leading Retailer and Distributor Pharm Yarok and Rosen High Way Strategically located, best in class retailer with approximately CAD$8 million...
Subversive Acquisition LP Announces InterCure’s Letter of Intent Relating to the Acquisition of a Multi-National Medical Cannabis Producer, Better Holdings InterCure Signs Letter of Intent with Cann Pharmaceutical Ltd....
Exclusive Interview with Kanabo Founder, CEO and Executive Director Avihu Tamir Vaporization is a common delivery method for recreational cannabis in the North American market, but medical cannabis consumers...
Cronos Group Reports 2020 Fourth Quarter and Full-Year Results Announces plans to launch Happy Dance™ in ULTA Beauty™ Cronos Israel continues to grow the PEACE NATURALS™ brand in the...
IM Cannabis to Acquire Trichome in Landmark Transaction – Establishes Global Growth Platform and Leading Multi-Country Operator Combined Company will be a fully-integrated global leader in adult-use recreational and...
MONCTON, New Brunswick, August 14, 2020–(BUSINESS WIRE)–Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis,...
Organigram and Canndoc Sign International Strategic Agreement Organigram to supply Israeli leader Canndoc with up to 6,000kg of dried flower in multi-year strategic agreement; Organigram’s largest international deal to...
Syqe Medical Receives Regulatory Approval to Release World’s First Drug Delivery Device for Precise Dosing of Cannabis Leading pharma-tech company launches its first-in-class, pharmaceutical-grade cannabis inhaler in Israel; enabling...
Cronos Group Opens Cronos Device Labs, New Global R&D Center in Israel Accelerates Efforts to Develop Next-Generation Vaporizer Products Designed Specifically for Cannabinoids TORONTO, May 07, 2019 (GLOBE NEWSWIRE)...
Cannabis Science Pioneer Tikun Olam Announces Closing of $7 Million Convertible Promissory Notes Financing NEW YORK, NY (March 9, 2018) – Tikun Olam USA, the world pioneer in cannabis research,...
Bazelet Completes New World-Scale Manufacturing Plant and Develops New Patent-Pending Cannabis Formulations with Improved Therapeutic Effects TEL AVIV, Israel, November 28, 2017 /PRNewswire/ — Israeli Medical Cannabis Company Bazelet...
Cronos Establishes International Low Cost Production in Israel TORONTO, Sept. 6, 2017 /CNW/ – Cronos Group Inc. (TSXV: MJN) (OTC: PRMCF) (“Cronos” or the “Company”) is pleased to announce...
